This inventor holds 2 USPTO granted patents. Top assignee: Kabivitrum Ab. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: Bohdan Pavlu: Innovator in Hemophilia Treatment
Introduction
Bohdan Pavlu is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of biotechnology, particularly in the treatment of hemophilia. With a total of 2 patents, his work focuses on developing biologically active fragments of human antihemophilic factor.
Latest Patents
Pavlu's latest patents include innovative methods for creating novel, biologically active fragments of human antihemophilic factor. These patents detail processes for their preparation, pharmaceutical formulations containing these fragments, and their application in treating patients suffering from hemophilia. His research aims to improve the quality of life for individuals affected by this condition.
Career Highlights
Bohdan Pavlu is associated with Kabivitrum AB, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, contributing to the understanding and treatment of hemophilia.
Collaborations
Pavlu collaborates with esteemed colleagues, including Lars-Olof Andersson and Nanna Forsman. Their combined expertise enhances the research and development initiatives at Kabivitrum AB.
Conclusion
Bohdan Pavlu's innovative work in the field of hemophilia treatment exemplifies the impact of biotechnology on healthcare. His patents and collaborations reflect a commitment to improving patient outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile